ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

The Christie at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

The Christie takes part in 17 sessions at ESMO 2026 in Madrid. Its program explores treatment outcomes, resistance and new approaches across lung, prostate and other cancers. Topics include immune therapy-related pancreatic toxicity and cellular engineering approaches for lung cancer.

OrganizationESMO 2026 Attendance
The Christie
Manchester, United Kingdom
Cancer centre & hospital
Specialist cancer hospital and NHS foundation trust in Manchester, United Kingdom.
Poster
Fri Oct 23
13:00–15:00
Association of serum sodium levels with survival outcomes in a large real-world advanced cancer cohort treated with immune checkpoint inhibitors
ePoster session 23
Lung & thoracic cancersMelanoma & skin cancersSarcoma, CNS, head & neck and rare cancersGenitourinary cancers
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Chair
Sat Oct 24
08:30–10:00
Metastases: Understanding and targeting cancer spread
with Vall d'Hebron Institute of Oncology (VHIO)
Biomarkers & precision oncology
Satellite
Sat Oct 24
19:05–19:25
The value of time leading the choice of maintenance therapy
PharmaMar - More time for patients: Reframing the course of ES-SCLC
Lung & thoracic cancers
Poster
Sun Oct 25
12:00–12:45
A causal analysis of body composition and overall survival in radically treated bladder cancer patients
Sunday Poster Display session 2
Genitourinary cancers
Talk
Sun Oct 25
14:45–15:05
Perspectives in cellular engineering for lung cancer
Coming soon to your clinic? New therapies and approaches for lung cancer
Lung & thoracic cancers
Poster
Mon Oct 26
12:00–12:45
Advanced lung cancer inflammation index identifies long-term survivors (LTS) after chemo-immunotherapy (CT-IO) in ES-SCLC: The INSPIRE study
Monday Poster Display session 4
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Understanding real-world outcomes
Monday Poster Display session 3
Sarcoma, CNS, head & neck and rare cancersLung & thoracic cancers
Poster
Mon Oct 26
12:00–12:45

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at The Christie

Tell us what you sell and we’ll find the people at The Christie most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction